ISDA

Entry Detail

PDB ID:

2J4Z

Keywords:

TRANSFERASE

Title:

Structure of Aurora-2 in complex with PHA-680626

Biological Source:

Source Organism:

HOMO SAPIENS

Host Organism:

SPODOPTERA FRUGIPERDA

PDB Version:

Deposition Date:

2006-09-08

Release Date:

2006-11-06

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.00 Å

R-Value Free:

0.24

R-Value Work:

0.21

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:SERINE THREONINE-PROTEIN KINASE 6
Chain IDs:A, B
Chain Length:306
Number of Molecules:2
Biological Source:HOMO SAPIENS

UniProt ID:O14965 Pfam ID:PF00069 EC:2.7.11.1

Ligand Molecules

626

ARS

Primary Citation

1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: identification of a potent Aurora kinase inhibitor with a favorable antitumor kinase inhibition profile.

Fancelli, D, Moll, J, Varasi, M, Bravo, R, Artico, R, Berta, D, Bindi, S, Cameron, A, Candiani, I, Cappella, P, Carpinelli, P, Croci, W, Forte, B, Giorgini, M.L, Klapwijk, J, Marsiglio, A, Pesenti, E, Rocchetti, M, Roletto, F, Severino, D, Soncini, C, Storici, P, Tonani, R, Zugnoni, P, Vianello, P.Show

J. Med. Chem. 49 7247 7251 (2006)

PMID: 17125279 DOI: 10.1021/jm060897w

Abstact

The optimization of a series of 5-phenylacetyl 1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole derivatives toward the inhibition of Aurora kinases led to the identification of compound 9d. This is a potent inhibitor of Aurora kinases that also shows low nanomolar potency against additional anticancer kinase targets. Based on its high antiproliferative activity on different cancer cell lines, favorable chemico-physical and pharmacokinetic properties, and high efficacy in in vivo tumor models, compound 9d was ultimately selected for further development.

Legend

Protein

Chemical

Disease

Primary Citation of related structures